Patent · US Expired

Quinoline derivatives

US6696467B2 · kind B2 · utility

8Cited by

7References

22Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Patrizio Mattei · Riehen, CH
Werner Mueller · Cologne, DE
Werner Neidhart · Hagenthal-le-Bas, FR
Matthias Nettekoven · Weil am Rhein, DE
Philippe Pflieger · Schwoben, FR

Key dates

Filing date	Feb 4, 2003
Grant date	Feb 24, 2004
Priority date	—
Expiry date	Feb 4, 2023

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of general formula I as well as pharmaceutically acceptable salts and esters thereof, are potent inhibitors of neuropeptide Y and can be used in the form of pharmaceutical preparations for the treatment or prevention of various disease states and related morbidities including obesity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.